Yi H - Search Results

1

Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma.

Li F, Wang S, Wang Y, Lv Z, Jin D, Yi H, Fu L, Zhai S, Xiao T, Mao Y. Li F, et al. Among authors: yi h. Front Immunol. 2023 Feb 9;14:1101649. doi: 10.3389/fimmu.2023.1101649. eCollection 2023. Front Immunol. 2023. PMID: 36845145 Free PMC article.

2

Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma.

Yuan L, Li F, Wang S, Yi H, Li F, Mao Y. Yuan L, et al. Among authors: yi h. Front Oncol. 2021 Aug 2;11:719812. doi: 10.3389/fonc.2021.719812. eCollection 2021. Front Oncol. 2021. PMID: 34408984 Free PMC article.

3

Moving forward: the nationwide advertising ban of areca nut in China.

Yi H, Yuan L, Mao Y. Yi H, et al. Oral Oncol. 2021 Nov;122:105590. doi: 10.1016/j.oraloncology.2021.105590. Epub 2021 Oct 23. Oral Oncol. 2021. PMID: 34700282 No abstract available.

4

Comment on "High population burden of Omicron variant (B.1.1.529) is associated with the emergence of severe hepatitis of unknown etiology in children".

Yi H, Lin Y, Lu B, Mao Y. Yi H, et al. Int J Infect Dis. 2022 Sep;122:1007-1008. doi: 10.1016/j.ijid.2022.07.058. Epub 2022 Jul 28. Int J Infect Dis. 2022. PMID: 35908722 Free article. No abstract available.

5

Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker.

Yi H, Lin Y, Li Y, Guo Y, Yuan L, Mao Y. Yi H, et al. J Immunol Res. 2022 Jul 28;2022:4355890. doi: 10.1155/2022/4355890. eCollection 2022. J Immunol Res. 2022. PMID: 35935585 Free PMC article.

6

The origin of severe hepatitis of unknown aetiology in children: SARS-CoV-2 or adenovirus?

Yi H, Lin Y, Lu B, Mao Y. Yi H, et al. J Hepatol. 2023 Jan;78(1):e16-e18. doi: 10.1016/j.jhep.2022.08.032. Epub 2022 Sep 5. J Hepatol. 2023. PMID: 36067884 No abstract available.

7

Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis.

Li F, Zhai S, Lv Z, Yuan L, Wang S, Jin D, Yi H, Fu L, Mao Y. Li F, et al. Among authors: yi h. Front Oncol. 2022 Nov 10;12:968517. doi: 10.3389/fonc.2022.968517. eCollection 2022. Front Oncol. 2022. PMID: 36439448 Free PMC article.

8

Risk and prognosis of secondary thoracic cancers after radiation therapy for esophageal cancer.

Yi H, Li S, Lin Y, Li F, Wang S, Jin D, Lv Z, Fu L, Mao Y. Yi H, et al. J Gastroenterol Hepatol. 2023 Jun;38(6):930-939. doi: 10.1111/jgh.16156. Epub 2023 Mar 6. J Gastroenterol Hepatol. 2023. PMID: 36811199

9

Virtual Reality: Pioneering the Future of Precision in Anatomical Partial Lobectomy.

Hong Q, Chen H, Yi H, Mu J, Mao Y. Hong Q, et al. Among authors: yi h. Ann Surg Oncol. 2024 Nov;31(12):7665-7667. doi: 10.1245/s10434-024-16119-6. Epub 2024 Aug 27. Ann Surg Oncol. 2024. PMID: 39192010 No abstract available.

10

Exosomes in esophageal cancer: Promising nanocarriers in cancer progression, diagnosis, prognosis, and therapy.

Yuan L, Ji H, Cao Y, Yi H, Leng Q, Zhou J, Mei X. Yuan L, et al. Among authors: yi h. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Sep-Oct;16(5):e1989. doi: 10.1002/wnan.1989. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024. PMID: 39217461 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,466 results

Search Page

Filters